ACCESSION: MSBNK-SMB_Measured-HSA001P0153010
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'17_posi_16232': {'bp': 621898.0, 'sum': 1255683.0}, '12_posi_16238': {'bp': 616843.0, 'sum': 1239971.0}, '3_posi_16228': {'bp': 585138.0, 'sum': 1213543.0}, '16_posi_16238': {'bp': 583547.0, 'sum': 1222138.0}, '9_posi_16220': {'bp': 581244.0, 'sum': 1192583.0}, '14_posi_16237': {'bp': 575417.0, 'sum': 1169561.0}, '13_posi_16217': {'bp': 565219.0, 'sum': 1133168.0}, '6_posi_16195': {'bp': 537668.0, 'sum': 1135659.0}, '5_posi_16230': {'bp': 519364.0, 'sum': 1073964.0}, '15_posi_16197': {'bp': 513964.0, 'sum': 1059360.0}, '18_posi_16210': {'bp': 504960.0, 'sum': 1070266.0}}
COMMENT: RETENTION_TIME_STDEV 0.029
COMMENT: PRECURSOR_M/Z_RAW 153.113102
COMMENT: PRECURSOR_M/Z_STDEV 0.000049
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.197; C7H12N4; [M+H]+; delta(ppm) -0.197231
COMMENT: PROPOSED_MF MS-FINDER 2.994; C7H12N4; [M+H]+; delta(ppm) -0.201447
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.348; C7H12N4; [M+H]+; delta(ppm) -0.201447
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.139; C9H14NO; [M+H]+; delta(ppm) -8.970444
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.201447
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.866; C7H12N4; [M+H]+; delta(ppm) -0.201447
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.744; C4H13FN4O; [M+H]+; delta(ppm) -7.664181
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.690; C9H14NO; [M+H]+; delta(ppm) -8.970444
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.476; C3H15N5P; [M+H]+; delta(ppm) -2.220227
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.201447
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.996; KYAGGLONXREQED-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.916; RWSWNQOCJVPCMF-UHFFFAOYSA-N; [M+H]+; 5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.566; RMTCWOLYVMOKBR-UHFFFAOYSA-N; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.553; SAYXVILDUZLWGX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.386; FHYDQGOVTLQZSZ-UHFFFAOYSA-N; [M+H]+; N'-pyrimidin-2-ylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.342; MHMOUFDAKNJXSK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.208; KFJYLCFNRATSPE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.133; ASGQRNXDYZQNPS-UHFFFAOYSA-N; [M+H]+; 4-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.037; QDEKQIPSPLAOPI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.012; SANLPMMCLNQJPP-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.996; FILWPDPGRBPZDL-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.975; QFOSWZIUPHQBRK-UHFFFAOYSA-N; [M+H]+; 8-methyl-2,3,6,7-tetrahydroimidazo[1,2-a]pyrimidin-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.937; OQHDZWPNEOFLCW-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.922; GMVWRTAXMQPIBG-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.915; IMQGJTWGILNPMZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.910; YPPVPNFMCXRUCC-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.878; DAAKLDCBWHWWNI-RMKNXTFCSA-N; [M+H]+; N-methyl-N-[(E)-(1-methylimidazol-2-yl)methylideneamino]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.865; KLDLJJRSWZYEFL-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.813; KHDBXRADZIIFBK-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclopropyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.813; MSQSNZKVWZTSDJ-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.808; KELKBKXPSNKQRJ-UHFFFAOYSA-N; [M+H]+; [1-(cyclopropylmethyl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.807; NNTDOOSCXNZOBK-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.796; JBICIOACIKMMJM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-N,N-dimethylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.794; GESFEOZCDXMGFO-UHFFFAOYSA-N; [M+H]+; 2-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.786; JUYYERAJUGNAKT-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.785; IFPQNVUJBNWAGL-UHFFFAOYSA-N; [M+H]+; 2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.785; QCAHQEGOYONBHI-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.784; GFUMZGPBCAJZHH-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.776; WJXSFSALUZCCJQ-UHFFFAOYSA-N; [M+H]+; 3,8-dimethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.761; DLVUEWDMHXYYAO-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.759; FNMXKIOFMCGDMH-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.756; LGIWBPLJDKOQSX-UHFFFAOYSA-N; [M+H]+; 4-(2H-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.754; KGXBEJFERUBKKY-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; PWQFWTMOGJDMLO-UHFFFAOYSA-N; [M+H]+; [3-(1,2,4-triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; ZEFRABOWIHXNKA-UHFFFAOYSA-N; [M+H]+; 3-methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.752; DKRJNDYSGMPAAB-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.746; XNHWFJRPVBJRPR-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.744; NMHSRADHFBXGAG-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.743; KGLMRCGIKAKFCH-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.741; KNGLSUWCXOCEKZ-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; PWEGFMVXXGYUTH-UHFFFAOYSA-N; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.736; MJIWVLBPVFCYJB-ZETCQYMHSA-N; [M+H]+; 1-[[(2S)-pyrrolidin-2-yl]methyl]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.732; BXSGLNRNBMUCIM-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; OIZMGVQEOVIMOL-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.726; AGIXGQFDUZRXCT-UHFFFAOYSA-N; [M+H]+; 1-(pyrrolidin-2-ylmethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.725; URSHNSSBVLGWNY-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.724; FYKDYYGNYLGWCA-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.722; YRQUFBNVMMTCEX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.722; UOGYOJNDIFVZLJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.719; COBJBBVQXYDCJU-UHFFFAOYSA-N; [M+H]+; N-[(1-methyltriazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.717; HSBDIERXOJWHKI-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.717; XDUNSNMMXUKPIN-ZCFIWIBFSA-N; [M+H]+; 4-methyl-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.713; GREJTVKJTDGUQI-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.710; XMNCTKKZAFGKBV-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; IZHAMQUVVWJULL-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.686; NYWMQSMKGVCQED-LURJTMIESA-N; [M+H]+; 3-methyl-5-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.668; VFXLTLDREFAZCG-UHFFFAOYSA-N; [M+H]+; [3-(triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.561; OEURBUBEWIXBKU-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.308; HWXAKUICDBKUDB-UHFFFAOYSA-N; [M+H]+; 4-azidobicyclo[2.2.1]heptan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.463; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.229; DKRJNDYSGMPAAB; [M+H]+; 1,2,4-triazolo[4,5-a]piperidin-3-ylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.299; PWEGFMVXXGYUTH; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.070; COBJBBVQXYDCJU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.954; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.695; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.101; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -47.986; OSFQDBIPRHMIDT; [M+H]+; 2-Isocyano-1-piperazin-1-ylethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.157; TVNPPGKJDWUPQW; [M+H]+; 6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.967; ZJXICXCNTQYJNT; [M+H]+; Bis-(imidazolin-1-yl)methane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -69.746; MRPCMLHUFNDYNR; [M+H]+; 7-methanidyl-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.322; SIRVOPPMPRBCBU; [M+H]+; N-[2-(triazol-1-yl)ethyl]prop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.006; GUUQVRXXRYXGOH; [M+H]+; 2-[2-[Cyanomethyl(methyl)amino]ethylamino]acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.182; XUOCFFCHJOOBLN; [M+H]+; N-[2-(1,2,4-triazol-4-yl)ethyl]prop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.920; VGBGZWCLSJIOTL; [M+H]+; 3-[(2-Isocyanoethylamino)methylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.179; PJHOOSQDPCIQGA; [M+H]+; 2-[3-(2-iminoethyl)-2H-imidazol-1-yl]ethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.759; SKNDGNMGZNZZKN; [M+H]+; 3-(2,4-Dihydroimidazol-3-ylmethyl)-2,4-dihydroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.284; OSFQDBIPRHMIDT; [M+H]+; 2-Isocyano-1-piperazin-1-ylethanimine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 32.574
MS$FOCUSED_ION: PRECURSOR_M/Z 153.113442
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-5900000000-ed4a4b9dc2b3ee2138ec
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495038 27.5972 56.050136 0.8742 3.66 0.6455 11 f{C3H6N1}/0.50ppm,p-C4H7N3
  69.0447426 121.5946 69.045368 0.2897 7.97 0.5545 11 f{C3H5N2}/0.26ppm,p-C4H8N2
  71.0603823 212.3309 71.060996 0.2111 10.40 0.8182 11 f{C3H7N2}/0.11ppm,p-C4H6N2
  83.0603818 112.3783 83.060885 0.2649 6.14 0.7727 11 f{C4H7N2}/0.09ppm,p-C3H6N2
  85.0760326 270.8443 85.076512 0.1528 12.53 0.8636 11 f{C4H9N2}/0.09ppm,p-C3H4N2
  97.0759123 12.0475 97.076257 1.0404 2.16 0.1182 11 f{C5H9N2}/-1.16ppm,p-C2H4N2
  109.0760144 7.4715 109.076251 2.3745 1.05 0.4762 8 f{C6H9N2}/-0.09ppm,p-C1H4N2
  110.0713290 47.7048 110.071556 0.8358 4.51 0.0545 11 f{C5H8N3}/0.50ppm,p-C2H5N1
  124.0869449 45.8325 124.087000 0.8139 3.98 0.8364 11 f{C6H10N3}/0.17ppm,p-C1H3N1
  126.1026223 53.3926 126.102649 0.8485 3.45 0.8636 11 f{C6H12N3}/0.38ppm,p-C1H1N1
  136.0868576 35.8176 136.086764 0.8671 5.54 0.6545 11 f{C7H10N3}/-0.49ppm,p-H3N1
  153.0772142 22.0298 153.077110 1.8814 3.79 0.0273 11 ?
  153.1133960 999.0000 153.113292 0.1437 0.00 1.0000 11 f{C7H13N4}/-0.50ppm,p
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  56.049504 27.60 27
  69.044743 121.59 121
  71.060382 212.33 212
  83.060382 112.38 112
  85.076033 270.84 270
  97.075912 12.05 12
  109.076014 7.47 7
  110.071329 47.70 47
  124.086945 45.83 45
  126.102622 53.39 53
  136.086858 35.82 35
  153.077214 22.03 22
  153.113396 999.00 999
//
